Navigation Links
Amilpar Acquires ESHO
Date:2/1/2010

RIO DE JANEIRO, Feb. 1 /PRNewswire-FirstCall/ -- Amil Participacoes S.A. (Bovespa: AMIL3) ("Amilpar"), in accordance with CVM (the Brazilian Securities and Exchange Commission) Instruction 358/02, informs that today it exercised the option to purchase 100% of ESHO - Empresa de Servicos Hospitalares Ltda, as established in the Management and Hospital Call Option Agreement, signed on October 18, 2007, in the total amount of R$ 60.1 million, set after the auditing process, according to the decision taken by Amilpar's Board of Directors, in a meeting held on November 9, 2009.

The payment will be made in 48 monthly and successive installments, adjusted by the CDI (average interbank deposit rate in Brazil), the first installment with maturity on February 18 and the other installments on the 15th day of each month.

The main assets that comprise ESHO are the three hospitals which were already managed by Amilpar, as established in the Management and Hospital Call Option Agreement, and this acquisition is the accomplishment of the compromise made by Amilpar at the time of its IPO. Hospital information:

(i) CardioTrauma Hospital, located at Rua Farme de Amoedo, Ipanema, in the city and state of Rio de Janeiro, has 46 beds;

(ii) Mario Lioni Hospital, located at Rua Ana Neri, Bairro Vinte e Cinco de Agosto, Duque de Caxias, in the state of Rio de Janeiro, has 120 beds;

(iii) Hospital Paulistano, located at Rua Martiniano de Carvalho, the corner with Rua Pio XII, Bairro Liberdade, in the city and state of Sao Paulo,
'/>"/>

SOURCE Amil Participacoes S.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amilpar - Relevant Fact - Public Offer Result
2. Amilpar - Press Release
3. Amilpar - Distribution of Interest on Capital Stock
4. Amilpar - Relevant Fact
5. Amilpar - Press Release - Commercial Papers
6. Amilpar - Relevant Fact - Public Offer
7. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
8. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
9. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
10. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
11. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 OSF Saint Paul Medical ... System , was welcomed into the Ministry April 1, ... Msgr. Paul E. Showalter, vicar general of the Catholic ... Dedication culminated a nearly year-long transition process for the ... hospital. Speakers for the morning ceremony included Sister Judith ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
(Date:4/1/2015)... 2015 eMindful , the provider ... its executive team with the addition of veteran digital ... , In his new role, Suissa is leading ... across the business and consumer portals. He also is ... company’s online community. His hiring was a result ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 When annoying ... occur, waiting days or weeks for an appointment with ... same and next day appointments haven’t been possible within ... Forefront Dermatology’s offices have noticed demand for this level ... “We realize how important relief or answers to dermatological ...
(Date:4/1/2015)... EB Medicine, leading publisher of clinical ... and Hospital Medicine Practice, is pleased to announce ... the content from its flagship publication, Emergency ... available on iPhones, iPads and Android smartphones and ... develop mobile applications for EB Medicine’s journals is ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3
... ... PHILADELPHIA, Pennsylvania, November 30 , ... Healthcare Reform and ARRA Momentum , Elsevier, a ... (EHR) integrated solutions, today,announced a new online resource center for American Recovery ...
... The U.S. Centers for Disease Control and Prevention estimate ... States are infected with HIV/AIDS. New research from North ... are minorities and do not have health insurance, and ... education and prevention efforts in minority and low-income populations. ...
... of Navarra Hospital has launched a series of clinical ... immunotherapy treatment. This approach involves the application of personalised ... patient him or herself and designed to combat glioblastomas, ... The new therapy is administered to participating patients combined ...
... heavily more often than younger people, study finds, , MONDAY, ... drinkers consume more alcohol than their younger counterparts, a new ... the same effect. , According to a study released ... 60 consume more than 40 drinks a week, on average. ...
... , SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/ - ... Mellow Hope finalized contract details with one of the largest ... increase in revenues for Hard to Treat Diseases in the ... company secures the supply of raw pharmaceutical material to the ...
... , ROCKLAND, Mass., Nov. 30 EMD Serono, an ... received a refuse to file letter from the US Food ... for Cladribine Tablets, EMD Serono,s proprietary investigational oral formulation of ... (MS). , "The company will work closely with the ...
Cached Medicine News:Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... WALNUT CREEK, Calif. , April 1, 2015 /PRNewswire/ ... a huge difference.  When this is the case, having ... changer.  No one understands this truth better than software ... test laboratory management software QATrax.  Recently, the company announced ... a very enthusiastic response from clients. ...
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an offering of $60.0 million aggregate principal ... (the "notes") in a private placement to qualified ... Securities Act of 1933, as amended (the "Act"). ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... of its ongoing,efforts to develop research tools that ... disease, The Michael J. Fox,Foundation announced the launch ... the Foundation seeks to drive the creation,and testing ... with a personal,computer and an Internet connection to ...
... March 19 FluoroPharma Inc., a company,developing breakthrough ... (PET) market, announced commencement of Phase,I clinical trials ... the proposed studies. The Phase I trial is ... safety, distribution and dosimetry,of BFPET as a PET ...
Cached Medicine Technology:New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials 2FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2
... System combines the legendary accuracy of the ... Windows* software. It integrates seamlessly into ... that enhance your clinical capabilities in an ... future of EP. The intended use ...
... combined with a stimulation lead ... Temporary Pacemaker can be used ... pacing is indicated. The device ... as well as diagnostic purposes ...
... offers the world's broadest line of endocardial ... are available in both torque control and ... curve choices and electrode spacing options. ... for use in temporary, transvenous right ventricular ...
... WorldHeart's Novacor LVAS is an ... pulsatile circulatory support for patients ... LVAS has been implanted in ... is the first mechanical circulatory ...
Medicine Products: